Industry Insights
Stay informed to stay ahead of your competition with the latest industry trends and insights.
8 feeds
303 followers
43 articles/week
Navigating the Impact of the Inflation Reduction Act: Assessing Current Realities and Future Trajectory
AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod
Gilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
326 followers
41 articles/week
Biotech, Pharmaceutical and Clinical Research News | BioSpace
FollowRSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
358 followers
46 articles/week
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results
Reporting from the frontiers of health and medicine
634 followers
73 articles/week
Opinion: STAT readers respond to First Opinion essays on site-neutral payments, free medical school tuition, and more
Cattle testing for H5N1 bird flu will be more limited than USDA initially announced
Biden administration punts menthol cigarette rule indefinitely
STAT+: Momentum builds for House bill cracking down on Chinese biotechs
Contains all the PharmaTimes latest World News.
289 followers
10 articles/week
Scientists reveal new method that could reduce waste from drug manufacturing
Two RNA-binding proteins could contribute to cancer therapy development
CMT Research Foundation funds study investigating treatment for CMT1X disease
MPE launches English Myeloma and AL Amyloidosis European Clinical Trial Navigator
Pharmaceuticals news and pharmaceutical industry analysis - FT.com
FollowThe latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
408 followers
16 articles/week
Science is closing in on the frailties of old age
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
BioPharma
239 followers
23 articles/week
354 followers
3 articles/week
Build your own newsfeed
Ready to give it a go?
Start a 14-day trial, no credit card required.